🇺🇸 temozolomide or PCV in United States

FDA authorised temozolomide or PCV on 27 October 2025

Marketing authorisation

FDA — authorised 27 October 2025

  • Application: ANDA219265
  • Marketing authorisation holder: CARNEGIE
  • Local brand name: LOMUSTINE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

Frequently asked questions

Is temozolomide or PCV approved in United States?

Yes. FDA authorised it on 27 October 2025.

Who is the marketing authorisation holder for temozolomide or PCV in United States?

CARNEGIE holds the US marketing authorisation.